G20 urges ‘voluntary’ tech transfer amid IP row at WHO

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

G20 urges ‘voluntary’ tech transfer amid IP row at WHO

G20 health.jpg
A meeting of health ministers in Gujarat, India last week | Credit: Govt of India

A statement from health ministers arrived as negotiations over pandemic prevention measures continue at the WHO

G20 health ministers have hailed the importance of tech transfer and knowledge sharing to prevent future pandemics, but only on “voluntary and mutually agreed terms”.

An outcome statement, published after a two-day meeting of health ministers in Gujarat on Saturday, August 18, highlighted the need to improve access to vaccines, diagnostics, and therapies in developing countries.

Negotiations to achieve that aim are ongoing at the World Health Organization (WHO), which is preparing the text of a new pandemic preparedness treaty.

But developed countries have so far resisted lower-income nations’ demands to make rights owners share their intellectual property.

The shadow of that debate is visible in the wording of the G20 statement, says Ellen ‘t Hoen, director at Medicines Law & Policy in Amsterdam.

“This statement does not detract from the rights countries have to use compulsory patent licensing. But the G20 does seem to want to pre-empt the outcome of the pandemic treaty negotiations at the WHO by stressing voluntary measures,” she said.

As Managing IP has previously reported, low-to-middle income countries that want harder commitments on knowledge sharing face an uphill battle at the WHO.

WHO negotiators met in Geneva last month for the latest round of talks on the pandemic treaty, which has several chapters that could affect the global IP system.

The latest text, prepared by the bureau of the WHO’s Intergovernmental Negotiating Body, mostly promotes the voluntary sharing of know-how rather than any hard obligations.

India and South Africa, G20 members that have argued for tech transfer obligations on IP owners in other forums, signed the outcome statement over the weekend.

‘T Hoen said WHO member states should take a “more courageous approach” than shown either by the G20 or in the bureau draft of the pandemic treaty so far.

“‘Voluntary’ is how the world left it the last time around. That did not work out for most countries,” she said.

The outcome statement was agreed unanimously by G20 states, except Russia and China, which objected to a paragraph calling on Russian forces to withdraw from Ukraine.

more from across site and SHARED ros bottom lb

More from across our site

Junior lawyers aren’t unwilling to work hard, as some seniors believe; rather, they are rejecting traditional career advancement models that have limited payoff
Rebekah Gay discusses overcoming self-doubt, supporting the next generation of women lawyers, and how changing client demands are reshaping IP practice
New filing data suggests Germany's grip on UPC litigation remains strong, while Bardehle Pagenberg, Arnold Ruess, Hogan Lovells and Carpmaels notch up notable cases
In 27 years, KASS has expanded to seven countries in southeast Asia and is now eyeing further growth opportunities. Its CEO shares her perspective
Mine Güner discusses bridging law and business, taking the initiative, and why Taylor Swift helped put copyright on the map
Cindy Goh discusses why she launched Cheang & Ariff's IP department, the improving litigation environment in Malaysia and what to consider when using AI
Increased focus on adding patent litigation depth to the firm’s Dallas office was behind the boutique’s most recent hires
IPH's Canadian acquisitions are paying off on paper, but a couple of strong years may not be enough to show that the group's strategy has truly won over the market
Examiner statistics could help patent prosecution practitioners tailor strategies, turning an area of high variability into a potential competitive advantage
The England and Wales High Court’s ruling in Accord v Novartis may not rewrite the law on plausibility, but it does signal a pragmatic approach that could provide greater certainty for life sciences innovators
Gift this article